DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 990 filers reported holding DANAHER CORPORATION in Q3 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $19,483,000 | -17.2% | 192,903 | -22.2% | 0.04% | -14.6% |
| Q1 2016 | $23,529,000 | -0.2% | 248,033 | -2.3% | 0.04% | 0.0% |
| Q4 2015 | $23,581,000 | -3.7% | 253,877 | -11.7% | 0.04% | -14.6% |
| Q3 2015 | $24,499,000 | -67.5% | 287,517 | -67.3% | 0.05% | -64.4% |
| Q2 2015 | $75,274,000 | -0.9% | 879,473 | -1.7% | 0.14% | -6.2% |
| Q1 2015 | $75,963,000 | -1.0% | 894,743 | -0.1% | 0.14% | -6.5% |
| Q4 2014 | $76,734,000 | +11.1% | 895,276 | -1.5% | 0.15% | +2.0% |
| Q3 2014 | $69,058,000 | -26.6% | 908,895 | -23.9% | 0.15% | -25.6% |
| Q2 2014 | $94,023,000 | +4.0% | 1,194,242 | -0.9% | 0.20% | -4.7% |
| Q1 2014 | $90,409,000 | -2.6% | 1,205,442 | +0.3% | 0.21% | -2.7% |
| Q4 2013 | $92,786,000 | +21.7% | 1,201,887 | +9.3% | 0.22% | +13.5% |
| Q3 2013 | $76,248,000 | +91.9% | 1,099,944 | +75.2% | 0.19% | +59.5% |
| Q2 2013 | $39,736,000 | – | 627,742 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |